Home /
News
Stay at the forefront of drug delivery innovation in the contract development and manufacturing organization (CDMO) space. Explore our latest news and announcements, where the demands of today meet the possibilities of tomorrow.
Company announcement
Kindeva joins forces with Rocket Science Health to pioneer new Intranasal Delivery Platform
News filter
Virpax Pharmaceuticals selects Kindeva Drug Delivery as development partner for Diclofenac pMDI commercialization
April 27, 2022 Woodbury, MN — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) and Kindeva Drug Delivery will work together to advance the clinical program of the Virpax-developed Diclofenac topical spray film (Epoladerm™) in the United States. The product is being studied for the treatment of pain associated with osteoarthritis of the knee. Using Kindeva’s state-of-the-art facilities […]
Read moreLive-attenuated VEEV vaccine delivered by iDNA using microneedles is immunogenic in rabbits
March 11, 2022 – Medigen, Inc’s Dr. Irina Tretyakova and Dr. Peter Pushko in collaboration with Dr. John Vasilakos (Kindeva) and Dr. Tomai (3M) have published the manuscript titled Live-Attenuated VEEV Vaccine Delivered by iDNA using Microneedles is Immunogenic in Rabbits in Frontiers in Tropical Diseases, 2 Mar 2022. The authors demonstrate induction of neutralizing […]
Read moreViatris Inc. announces receipt of the first FDA approval for generic version of Symbicort® inhalation aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate inhalation aerosol), in partnership with Kindeva
PITTSBURGH and ST. PAUL, Minn., March 16, 2022 — Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that, Mylan Pharmaceuticals Inc., a Viatris subsidiary, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for BreynaTM (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), the first approved generic version of AstraZeneca’s Symbicort®. Breyna, […]
Read more
Kindeva Drug Delivery to manufacture new, greener inhalers at UK manufacturing site to help cut carbon emissions
February 16, 2022 – One of the UK’s biggest asthma inhaler manufacturers has today announced its intention to invest in its UK manufacturing site to support the development of a new generation of greener inhalers, designed to help support the National Health Service (NHS) to cut a contributor to its emissions. The new inhalers will […]
Read moreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.